Thursday , September 19 2019
Home / india / FDA approves first non-pharmaceutical treatment of AD / HD: stimulation of external trigeminal nerve (Etns)

FDA approves first non-pharmaceutical treatment of AD / HD: stimulation of external trigeminal nerve (Etns)



John Conde DC, DACNB Special for Boca and Delray newspapers

Attention Deficiency Hyperactivity Disorder (AD / HD) is a brain disorder characterized by negligence, hyperactivity and impulsiveness. In essence, an individual shows concentration problems, organizational difficulties, focusing problems, constantly moving, running over, and making quick action. These behavioral tendencies give rise to problems in creating friends and excellence in academic circles. There are 3 million US cases a year, an epidemic.

Traditionally, the US Food and Drug Administration (FDA) has only approved pharmaceuticals for the treatment of AD / HD. The class of typically approved drugs is a stimulant. It is known that stimulants increase vigilance, attention, and energy by raising the level of key chemicals in the brain or dopamine. However, it is well known that the stimulants have significant long-term and short-term side effects such as sleep problems, reduced appetite, weight loss, increased blood pressure, increased heart rate, dizziness, headache, stomach pain, hallucinations, panic and psychosis. , Growing research over the past decade has focused on how to functionally change the status of the nervous system naturally through the use of ecological stimuli to increase the ability of brain-free brain remedies. These concepts are largely rooted in the second advancement in neuroscience in the 21st centuryst century called plastics. Plasticity is a neuroscience principle that says the brain can be altered or shaped or mapped in accordance with the ecological stimuli exposed to it at that time.

For the first time in the history of the FDA, non-pharmaceutical treatment is provided to help children suffering from AD / HD. External trigeminal nerve stimulation (eTNS) is a form of neuromodulation, more commonly known as nerve stimulation, where a light electrical pulse is applied to the trigeminal nerve in the brain. This electric impulse is carried out by bi-polar probes or electrodes located on different facial portions where the trigeminal nerve branches are most complete. Trigeminal nerve is mostly responsible for facial sensation. The main branches used are supraorbital nerve (SO), supratrohullar nerve (ST) and zygomaticotemporal nerve (ZTN). From the perspective of neuroscience, trigeminal nerve activation pulsates through the nerve and helps transmit "therapeutic signals" to brain parts thought to be involved in AD / HD. These propagating signals will help stabilize the unstable neurological activity seen in the brain of those suffering from AD / HD.

eTNS together with functional neurological rehabilitation really produces the most powerful outcomes in these children who suffer from AD / HD. Functional neurological rehabilitation uses environmental stimuli such as light, sound, smell and touch, as well as other sensory aspects to enhance the areas of deficit functions in the nervous system. Using the understanding of plasticity, brain activity is increased and stabilized, and a true long-term change can be made. These kids can be successful in school and sports and become incredibly organized adults.

Dr. John Conde is an authorized neuropsychologist, one in a thousand in the country. She has a diplomatic status through the American Chiropractic Neurology Board. It provides specialized care for severe neck pain, stiffness, tingling, dizziness, dizziness, fibromyalgia, migraine, AD / HD, autism and dyslexia. His office is located at Atlantic Grove in Delray Beach, FL and can be obtained at 561-330-6096, drconde@thecondecenter.com, and at www.thecondecenter.com


Source link